Home » Topics » Regulatory

Regulatory
RSS

FDA approves Vimpat as monotherapy for partial-onset seizures

Sep. 1, 2014

European Commission approves Bristol-Myers Squibb's Daklinza for HCV

Aug. 28, 2014

FDA approves Triumeq for HIV

Aug. 26, 2014

Apixaban granted FDA approval for DVT and PE

Aug. 22, 2014

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Aug. 21, 2014

FDA approves Genzyme's eliglustat for Type 1 Gaucher disease

Aug. 20, 2014

Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA

Aug. 19, 2014

FDA approves Belsomra for insomnia

Aug. 14, 2014

FDA approves oritavancin for acute bacterial skin and skin structure infections

Aug. 7, 2014

Octapharma's Nuwiq receives E.U. approval for hemophilia A

Aug. 6, 2014

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...